175 related articles for article (PubMed ID: 27465864)
1. Assessment of antigenic difference of equine influenza virus strains by challenge study in horses.
Yamanaka T; Nemoto M; Bannai H; Tsujimura K; Kondo T; Matsumura T; Gildea S; Cullinane A
Influenza Other Respir Viruses; 2016 Nov; 10(6):536-539. PubMed ID: 27465864
[TBL] [Abstract][Full Text] [Related]
2. Update of inactivated equine influenza vaccine strain in Japan.
Gamoh K; Nakamura S
J Vet Med Sci; 2017 Mar; 79(3):649-653. PubMed ID: 28163276
[TBL] [Abstract][Full Text] [Related]
3. Neutralization antibody response to booster/priming immunization with new equine influenza vaccine in Japan.
Yamanaka T; Nemoto M; Bannai H; Tsujimura K; Matsumura T; Kokado H; Gildea S; Cullinane A
J Vet Med Sci; 2018 Mar; 80(2):382-386. PubMed ID: 29237998
[TBL] [Abstract][Full Text] [Related]
4. Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.
Paillot R; Prowse L; Montesso F; Huang CM; Barnes H; Escala J
Vet Microbiol; 2013 Mar; 162(2-4):396-407. PubMed ID: 23146168
[TBL] [Abstract][Full Text] [Related]
5. Antigenic differences between equine influenza virus vaccine strains and Florida sublineage clade 1 strains isolated in Europe in 2019.
Nemoto M; Ohta M; Yamanaka T; Kambayashi Y; Bannai H; Tsujimura K; Yamayoshi S; Kawaoka Y; Cullinane A
Vet J; 2021 Jun; 272():105674. PubMed ID: 33941332
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
Paillot R; Prowse L; Donald C; Medcalf E; Montesso F; Bryant N; Watson J; Jeggo M; Elton D; Newton R; Trail P; Barnes H
Vet Immunol Immunopathol; 2010 Aug; 136(3-4):272-83. PubMed ID: 20400185
[TBL] [Abstract][Full Text] [Related]
7. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses.
Chambers TM; Quinlivan M; Sturgill T; Cullinane A; Horohov DW; Zamarin D; Arkins S; García-Sastre A; Palese P
Equine Vet J; 2009 Jan; 41(1):87-92. PubMed ID: 19301588
[TBL] [Abstract][Full Text] [Related]
8. Antibody responses induced by Japanese whole inactivated vaccines against equine influenza virus (H3N8) belonging to Florida sublineage clade2.
Yamanaka T; Bannai H; Nemoto M; Tsujimura K; Kondo T; Matsumura T
J Vet Med Sci; 2011 Apr; 73(4):483-5. PubMed ID: 21099188
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy of inactivated equine influenza (H3N8) virus vaccine in murine model.
Pavulraj S; Virmani N; Bera BC; Joshi A; Anand T; Virmani M; Singh R; Singh RK; Tripathi BN
Vet Microbiol; 2017 Oct; 210():188-196. PubMed ID: 29103691
[TBL] [Abstract][Full Text] [Related]
10. Concurrent vaccination against equine influenza and equine herpesvirus - a practical approach.
Gildea S; Sanchez Higgins MJ; Johnson G; Walsh C; Cullinane A
Influenza Other Respir Viruses; 2016 Sep; 10(5):433-7. PubMed ID: 27169603
[TBL] [Abstract][Full Text] [Related]
11. Antigenic and genetic analysis of H3N8 influenza viruses isolated from horses in Japan and Mongolia, and imported from Canada and Belgium during 2007-2010.
Motoshima M; Okamatsu M; Asakura S; Kuribayashi S; Sengee S; Batchuluun D; Ito M; Maeda Y; Eto M; Sakoda Y; Sodnomdarjaa R; Kida H
Arch Virol; 2011 Aug; 156(8):1379-85. PubMed ID: 21505822
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic methods applied to analysis of an outbreak of equine influenza in a riding school in which vaccine failure occurred.
van Maanen C; van Essen GJ; Minke J; Daly JM; Yates PJ
Vet Microbiol; 2003 Jun; 93(4):291-306. PubMed ID: 12713892
[TBL] [Abstract][Full Text] [Related]
13. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
Vaccine; 2009 Sep; 27(40):5530-7. PubMed ID: 19607950
[TBL] [Abstract][Full Text] [Related]
14. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
Lopez AM; Hecker R; Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA; Townsend HG
Vet Immunol Immunopathol; 2006 Nov; 114(1-2):103-10. PubMed ID: 16950519
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge.
Pouwels HG; Van de Zande SM; Horspool LJ; Hoeijmakers MJ
Vet Rec; 2014 Jun; 174(25):633. PubMed ID: 24795071
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA).
Galvin P; Gildea S; Arkins S; Walsh C; Cullinane A
Influenza Other Respir Viruses; 2013 Dec; 7 Suppl 4(Suppl 4):73-80. PubMed ID: 24224822
[TBL] [Abstract][Full Text] [Related]
17. Detection of antibodies to the nonstructural protein (NS1) of influenza A virus allows distinction between vaccinated and infected horses.
Ozaki H; Sugiura T; Sugita S; Imagawa H; Kida H
Vet Microbiol; 2001 Sep; 82(2):111-9. PubMed ID: 11423202
[TBL] [Abstract][Full Text] [Related]
18. Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short-term vaccine efficacy study.
Daly JM; Sindle T; Tearle J; Barquero N; Newton JR; Corning S
Equine Vet J; 2007 Sep; 39(5):446-50. PubMed ID: 17910270
[TBL] [Abstract][Full Text] [Related]
19. Genetic Analyses of an H3N8 Influenza Virus Isolate, Causative Strain of the Outbreak of Equine Influenza at the Kanazawa Racecourse in Japan in 2007.
Ito M; Nagai M; Hayakawa Y; Komae H; Murakami N; Yotsuya S; Asakura S; Sakoda Y; Kida H
J Vet Med Sci; 2008 Sep; 70(9):899-906. PubMed ID: 18840963
[TBL] [Abstract][Full Text] [Related]
20. Vaccine failure caused an outbreak of equine influenza in Croatia.
Barbic L; Madic J; Turk N; Daly J
Vet Microbiol; 2009 Jan; 133(1-2):164-71. PubMed ID: 18632226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
